EE116: Implications of Utilizing Survey Versus Administrative Claims Data to Evaluate the Cost of Diabetes Among Medicare Beneficiaries with Cancer: A Methods Study

EE205: Cost-Effectiveness Analysis of Empagliflozin Versus Albiglutide Among Individuals with Type 2 Diabetes in the US

EE366: Contrasting Three HbA1c Progression Equations Using the IQVIA Core Diabetes Model

HPR31: Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients

RWD38: Early Treatment Modification for Type 2 Diabetes in a US Real-World Population: Impact on Glycemic Control, Diabetic Complications, and Healthcare Utilization